ArticleInternal medicine (Tokyo, Japan)2022
Determinants of the Pathological Features of Renal Adverse Effects Due to Vascular Endothelial Growth Factor Signaling Inhibition.
Kiyoshi MoriPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.